과루인 및 과루인청혈플러스가 인간 탯줄 정맥 내피 세포(Human umbilicl vein endothelial cells, HUVECs)에서 염증인자 발현 억제에 미치는 영향
The Effect of Trichosanthes Kirilowii Maximowicz Extract and Trichosanthes Kirilowii Maximowicz Cheonghyeol Plus on Anti-Inflammatory Factor Expression in Human Umbilical Vein Endothelial Cells (HUVECs)
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: To examine the effects of Trichosanthes kirilowii Maximowicz extract (TE) and Trichosanthes kirilowii Maxi mowicz Cheonghyeol Plus Phellinus linteus Cheonghyeol plus (TCP) on anti-inflammatory factor expression in human umbilical vein endothelial cells (HUVECs). Methods: HUVECs were activated with TNF-α and then treated with TE and TCP. The expression levels were then measured for intracellular genes (KLF2, eNOS, MCP-1, ICAM-1, and VCAM-1), proteins (KLF2, eNOS, MCP-1, ICAM-1, VCAM-1, ERK, and JNK, p38), and extracellular biomarkers (ICAM-1, VCAM-1, and MCP-1). Results: 1. TCP at concentrations of 100 μg/mL or greater significantly increased the expression of KLF2 and eNOS intracellular genes and significantly decreased the expression of ICAM-1, VCAM-1, and MCP-1 genes compared to the control group. 2. TCP at concentrations of 100 μg/mL or greater significantly increased the expression of KLF2, eNOS proteins compared to the control group, and significantly reduced the expression of VCAM-1, ICAM-1, MCP-1, ERK, and p38 proteins. However, JNK protein phosphorylation showed no significant change compared to the control group. 3. TCP at concentrations of 100 μg/mL or more significantly decreased the production of MCP-1, ICAM-1, and VCAM-1 extracellular biomarkers compared to the control group. 4. TE at a concentration of 100 μg/mL did not cause any significant change in the expression of intracellular genes or proteins, in the production of the extracellular biomarker MCP-1, or in the amount of JNK protein compared to the control group. Other intracellular genes, proteins, and extracellular biomarker expression showed the same trend as observed with TCP exposure. Conclusion: This study experimentally confirmed that TE and TCP could be effective in preventing or inhibiting various inflammatory vascular diseases due to their anti-inflammatory effects.
Abstract
Objective: To examine the effects of Trichosanthes kirilowii Maximowicz extract (TE) and Trichosanthes kirilowii Maxi mowicz Cheonghyeol Plus Phellinus linteus Cheonghyeol plus (TCP) on anti-inflammatory factor expression in human umbilical vein endothelial cells (HUVECs). Methods: HUVECs were activated with TNF-α and then treated with TE and TCP. The expression levels were then measured for intracellular genes (KLF2, eNOS, MCP-1, ICAM-1, and VCAM-1), proteins (KLF2, eNOS, MCP-1, ICAM-1, VCAM-1, ERK, and JNK, p38), and extracellular biomarkers (ICAM-1, VCAM-1, and MCP-1). Results: 1. TCP at concentrations of 100 μg/mL or greater significantly increased the expression of KLF2 and eNOS intracellular genes and significantly decreased the expression of ICAM-1, VCAM-1, and MCP-1 genes compared to the control group. 2. TCP at concentrations of 100 μg/mL or greater significantly increased the expression of KLF2, eNOS proteins compared to the control group, and significantly reduced the expression of VCAM-1, ICAM-1, MCP-1, ERK, and p38 proteins. However, JNK protein phosphorylation showed no significant change compared to the control group. 3. TCP at concentrations of 100 μg/mL or more significantly decreased the production of MCP-1, ICAM-1, and VCAM-1 extracellular biomarkers compared to the control group. 4. TE at a concentration of 100 μg/mL did not cause any significant change in the expression of intracellular genes or proteins, in the production of the extracellular biomarker MCP-1, or in the amount of JNK protein compared to the control group. Other intracellular genes, proteins, and extracellular biomarker expression showed the same trend as observed with TCP exposure. Conclusion: This study experimentally confirmed that TE and TCP could be effective in preventing or inhibiting various inflammatory vascular diseases due to their anti-inflammatory effects.
참고문헌 (29)
- 정인경, "죽상경화증의 분자생물학적 조명", Endocrinology and Metabolism, 25(3), pp.166~170 (2010), 대한내분비학회
- Glass CK, "Atherosclerosis : The road ahead", Cell, 104(4), pp.503~516 (2001)
- Kim CJ, "Atherosclerosis and Inflammation", Korean Journal of Lipidology, 11(4), pp.413~419 (2001)
- 임창열, "Nitric Oxide와 종양", 대한내과학회지, 78(4), pp.430~436 (2010), 대한내과학회
- 이형란, "한국인의 eNOS 유전자 SNP 분석", 생명과학회지, 24(2), pp.181~185 (2014), 한국생명과학회[DOI]
- 김민지, "대식세포에서 MAPKs 및 NF-κB 신호전달 저해를 통한 서실 에탄올 추출물의 항염증 효과", KSBB Journal, 32(4), pp.352~360 (2017), 한국생물공학회[DOI]
- 원서영, "상황청혈플러스(PLCP)가 HUVEC에서 이상지질혈증 관련 항산화 작용 및 염증인자 발현 억제에 미치는 영향", 대한한의학회지, 41(2), pp.43~57 (2020), 대한한의학회[DOI]
- 채인철, "해백청혈플러스(AMCP)의 항산화 및 항염증 작용을 통한 죽상동맥경화 억제 효과", 동의생리병리학회지, 34(3), pp.126~135 (2020), 한의병리학회
- 이정구, "瓜蔞仁이 자궁경부암세포의 성장억제 및 세포고사에 미치는 영향", 동의생리병리학회지, 19(4), pp.965~972 (2005), 한의병리학회
- 신민교, "임상본초학", pp.369~372 (1997), 영림사
- 손지혜, "瓜蔞仁, 梔子, 白芷의 시험관내 항균 및 항염 효과", 대한한방부인과학회지, 26(1), pp.41~58 (2013), 대한한방부인과학회
- Statistics Korea, "Causes of death statistics in Korea", Statistics Korea, ~ (2020)
- Ito T, "Inflammatory cytokines and cardiovascular disease", Curr Drug Targets Inflamm Allergy, 2(3), pp.257~265 (2003)
- Cybulsky MI, "A major role for VCAM-1, but not ICAM-1, in early atherosclerosis", J Clin Invest, 107(10), pp.1255~1262 (2001)
- 한기훈, "대식세포와 동맥경화", 한국지질동맥경화학회, 2009(0), pp.80~82 (2009)
- 윤지선, "황칠나무 추출물의 고지혈증 완화 효과 스크리닝", Journal of Applied Biological Chemistry, 61(1), pp.1~8 (2018), 한국응용생명화학회
- Jaffe EA, "Culture of human endothelial cells derived from umbilical veins : identificationby morphologic and immunologic criteria", J Clin Invest, 52(11), pp.2745~2756 (1973)
- Turpaev KT, "Transcription Factor KLF2 and Its role in the regulation of inflammatory process", Biochemistry Moscow, 85(1), pp.54~67 (2020)
- 조준용, "지구성 운동이 본태성 고혈압 쥐 심장근의 eNOS, ET-1 mRNA와 골격근 eNOS 단백질 발현에 미치는 영향", 생명과학회지, 17(12), pp.1717~1722 (2007), 한국생명과학회
- 임현찬, "加味桃紅四物湯이 HUVEC cell 내에 eNOS, KLF2, ICAM-1, VCAM-1의 유전자 발현양에 대해 미치는 영향", 대한한방내과학회지, 39(1), pp.1~8 (2018), 대한한방내과학회
- Power CA. Proudfoot AE, "The chemokine system : novel broad spectrum therapeutic targets", Curr Opin Pharmacol, 1(4), pp.417~424 (2001)
- Takeya M, "Detection of monocyte chemoattratant protein-1in human atherosclerotic lesions by anti-monocyte chemoattractant protein-1 in monoclonal antibody", Hum Pathol, 24(5), pp.534~539 (1993)
- Seino Y, "Expression of monocyte chemoattactant protein-1 in vascular tissue", Cytokine, 7(6), pp.575~579 (1995)
- 김사현, "MCP-1에 의해 유도된 THP-1 유주에 미치는 Zerumbone의 영향", 대한임상검사과학회지, 50(2), pp.177~182 (2018), 대한임상검사과학회[DOI]
- 박형섭, "관상 동맥 협착의 진행과 혈중 Adiponectin, ICAM(Intercellular Adhesion Molecule)-1 농도와의 관계", Korean Circulation Journal, 34(9), pp.837~844 (2004), 대한심장학회
- Elice MJ, "VACAM-1 on activated endothelium interacts with the leukocyte integrin VAL-4 at a site distinct from the VLA-4", fibronectin binding site, 1990, pp.60(4), 577~584
- Su B, "Mitogen-activated protein kinase cascades and regulation of gene expression", Curr Opin Immunol, 8(3), pp.402~411 (1996)
- Chen YR, "The role of c-Jun N-terminal kinase(JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation", J Biol Cem, 271(50), pp.31929~31936 (1996)
- Kawasaki H, "Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells", J Biol Chem, 272(30), pp.18518~18521 (1997)